These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 26163269

  • 1. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
    Zhang Y, Yu H, Li H.
    Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
    [Abstract] [Full Text] [Related]

  • 2. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
    Zhang YS, Yu HY, Dong F, Li HZ.
    Zhonghua Wai Ke Za Zhi; 2016 Jul 01; 54(7):528-33. PubMed ID: 27373480
    [Abstract] [Full Text] [Related]

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.
    BJU Int; 2012 Jul 01; 110(1):76-83. PubMed ID: 22044519
    [Abstract] [Full Text] [Related]

  • 4. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
    Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH.
    World J Urol; 2016 Oct 01; 34(10):1465-72. PubMed ID: 26914818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H.
    Urology; 2003 Oct 01; 62(4):641-6. PubMed ID: 14550434
    [Abstract] [Full Text] [Related]

  • 8. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP.
    Eur Urol; 2018 May 01; 73(5):772-780. PubMed ID: 29398265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J, Heide J, Ribback S, Rausch S, de Martino M, Scharpf M, Haitel A, Zimmermann U, Pechoel M, Alkhayyat H, Shariat SF, Dombrowski F, Stenzl A, Burchardt M, Klatte T, Kroeger N.
    BJU Int; 2018 Jan 01; 121(1):84-92. PubMed ID: 28803448
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A, Arrighi N, Corti S, Legramanti S, Zanotelli T, Cozzoli A, Cunico SC, Simeone C.
    BJU Int; 2012 Dec 01; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [Abstract] [Full Text] [Related]

  • 12. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X, Li S, Xu Z, Wang K, Fu D, Liu Q, Wang X, Wu B.
    World J Surg Oncol; 2015 Feb 04; 13():14. PubMed ID: 25650039
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.
    Eur Urol; 2017 Aug 04; 72(2):300-306. PubMed ID: 28094055
    [Abstract] [Full Text] [Related]

  • 16. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H.
    Mayo Clin Proc; 2000 Dec 04; 75(12):1236-42. PubMed ID: 11126830
    [Abstract] [Full Text] [Related]

  • 17. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R.
    Urol Oncol; 2014 Jan 04; 32(1):43.e9-16. PubMed ID: 23911684
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.
    Nguyen DP, Vilaseca A, Vertosick EA, Corradi RB, Touijer KA, Benfante NE, Sjoberg DD, Russo P.
    World J Urol; 2016 Apr 04; 34(4):539-44. PubMed ID: 26215750
    [Abstract] [Full Text] [Related]

  • 20. Microscopic venous invasion is associated with disease free and cancer free survival in renal cell carcinoma.
    Sanli O, Zorba OU, Erdem S, Tezer M, Kilicar-Slan I, Esen T, Tunc M.
    Minerva Urol Nefrol; 2010 Dec 04; 62(4):347-53. PubMed ID: 20944535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.